Bioservo is evaluating potential Strategic Alternatives to accelerate commercialization
Bioservo Technologies (BIOS), a world-leading company in providing sophisticated soft muscle strengthening systems for people in need of extra strength and endurance, today announces that its Board of Directors is evaluating potential strategic alternatives to accelerate commercialization and enhance shareholder value.The Board has established a Special Committee composed of Management team members and members of the Board to evaluate a broad range of potential options, including the sale of part or all of the company, recapitalization, or other partnership opportunities, among other